Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Sep 15:14:973310.
doi: 10.3389/fnagi.2022.973310. eCollection 2022.

The long-term trend of Parkinson's disease incidence and mortality in China and a Bayesian projection from 2020 to 2030

Affiliations

The long-term trend of Parkinson's disease incidence and mortality in China and a Bayesian projection from 2020 to 2030

Fangyao Chen et al. Front Aging Neurosci. .

Abstract

Background: Parkinson's disease is a disabling degenerative disease of the central nervous system that occurs mainly in elderly people. The changes in the incidence and mortality of Parkinson's disease at the national level in China over the past three decades have not been fully explored. Methods: Research data were obtained from the Global Burden of Disease 2019 study. The trends of crude and age-standardized incidence and mortality rates by gender of Parkinson's disease in China were analyzed with the age-period-cohort model and the Joinpoint regression analysis. The effects of age, time period, and birth cohort on the incidence and mortality of Parkinson's disease were estimated. The gender- and age-specific incidence and mortality rates of Parkinson's disease from 2020 to 2030 were projected using the Bayesian age-period-cohort model with integrated nested Laplace approximations. Results: From 1990 to 2019, the annual percentage change of the age-standardized incidence rate was 0.8% (95% CI: 0.7%-0.8%) for males and 0.2% (95% CI, 0.2-0.2%) for females. And the age-standardized mortality rate for males was 2.9% (95% CI: 2.6%-3.2%) and 1.8% (95% CI: 1.5%-2.1%) for females. The results of the age-period-cohort analysis suggested that the risk and burden of Parkinson's disease continued to increase for the last several decades. Projection analysis suggested that the overall Parkinson's disease incidence will continue to increase for the next decades. It was projected that China would have 4.787 million Parkinson's patients by the year 2030, however, the mortality of Parkinson's disease for both genders in China may keep decreasing. Conclusion: Though the mortality risk may decrease, Parkinson's disease continues to become more common for both genders in China, especially in the senior-aged population. The burden associated with Parkinson's disease would continue to grow. Urgent interventions should be implemented to reduce the burden of Parkinson's disease in China.

Keywords: China; Parkinson’s disease; age-period-cohort; mortality and incidence; projection analysis.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Results of APC analysis for PD incidence from 1990 to 2019. (A) Longitudinal age curve of PD incidence (per 100,000) by gender. (B) Period RR by gender. (C) Cohort RR by gender. (D) Local drifts by gender.
Figure 2
Figure 2
Projected age-specific incidence of PD from 2020 to 2030 by gender. (A) Projected age-specific PD incidence for females. (B) Projected age-specific PD incidence for males.
Figure 3
Figure 3
Results of APC analysis for PD mortality from 1990 to 2019. (A) Longitudinal age curve of PD incidence (per 100,000) by gender. (B) Period RR by gender. (C) Cohort RR by gender. (D) Local drifts by gender.
Figure 4
Figure 4
Projected age-specific mortality of PD from 2020 to 2030 by gender. (A) Projected age-specific PD mortality for females. (B) Projected age-specific PD mortality for males.

Similar articles

Cited by

References

    1. Aarsland D., Batzu L., Halliday G., Geurtsen G., Ballard C., Ray Chaudhuri K., et al. . (2021). Parkinson disease-associated cognitive impairment. Nat. Rev. Dis. Primers 7:47. 10.1038/s41572-021-00280-3 - DOI - PubMed
    1. Ajdacic-Gross V., Schmid M., Tschopp A., Gutzwiller F. (2012). Birth cohort effects in neurological diseases: amyotrophic lateral sclerosis, Parkinson’s disease and multiple sclerosis. Neuroepidemiology 38, 56–63. 10.1159/000334632 - DOI - PubMed
    1. Anna K., Radosław K., Wojciech K. (2011). Educational level and cognitive impairment in patients with Parkinson disease. Neurol. Neurochir. Pol. 45, 24–31. 10.1016/s0028-3843(14)60056-6 - DOI - PubMed
    1. Ascherio A., Schwarzschild M. A. (2016). The epidemiology of Parkinson’s disease: risk factors and prevention. Lancet Neurol. 15, 1257–1272. 10.1016/S1474-4422(16)30230-7 - DOI - PubMed
    1. Beaton D., McLaughlin P. M., Orange J. B., Munoz D. P., Mandzia J., Abrahao A., et al. . (2022). Caregiving concerns and clinical characteristics across neurodegenerative and cerebrovascular disorders in the Ontario neurodegenerative disease research initiative. Int. J. Geriatr. Psychiatry 37, 1–19. 10.1002/gps.5727 - DOI - PubMed